P53 controls the growth and survival of cells by acting in response to a multitude of cellular stresses. It is, however, not yet fully understood how different p53 activation pathways result in either cell cycle arrest or apoptosis. We and others have described an N-terminally truncated p53 protein (p53/47) originating from a second translation initiation site in the p53 messenger RNA (mRNA), which can interact with p53 and impose altered stability and transactivation properties to p53 complexes. Here we show that cap-dependent and cap-independent mechanisms of initiation govern the translation of the p53 mRNA. Changes in synthesis of full-length p53 or p53/47 are regulated through distinct cell stress-induced pathways acting through separate regions of the p53 mRNA. We also show that some cytotoxic drugs require the presence of full-length p53 to induce apoptosis, whereas for others p53/47 is sufficient. This indicates that by harbouring alternative translation initiation sites, the p53 mRNA gives rise to different levels of the p53 isoforms which help to orchestrate the cell biological outcome of p53 activation in response to different types of cell stress. This sheds new light into the way p53 can integrate and differentiate a large multiplicity of changes in the cellular environment.
Introduction
The tumour suppressor protein p53 is ubiquitously expressed and functions to maintain cell integrity. Under normal conditions the p53 protein is present at low levels in a non-active state. In response to cell stress and DNA damage the levels and activity of p53 are rapidly increased, resulting in the trans-activation of p53 response genes and the induction of cell cycle arrest or apoptosis (Harris and Levine, 2005) . It is not fully understood how p53 can integrate such diversity of stress signals and even less clear is the way p53 activation can initiate an appropriate cell biological response by either arresting cell proliferation or unshackling apoptosis.
Recent research has focused mainly on the role of post-translational control as the major determinant of p53 levels and activity. A key player in this aspect is the E3 ubiquitin ligase Mdm2 (Haupt et al., 1997; Honda et al., 1997; Kubbutat et al., 1997) . The interaction between Mdm2 and the N-terminus of p53 obstructs p53-directed transcription and promotes the ubiquitination of lysine residues in the p53 C-terminus and the subsequent targeting of p53 for proteosomal degradation. The Mdm2 gene is itself a transcriptional target of p53 which has led to the proposal of a negative feedback loop between the two proteins, ensuring that p53 levels are kept low under normal conditions (de Rozieres et al., 2000) . In contrast, the translational regulation of the p53 mRNA has with some exceptions remained relatively unexplored. We recently described that the translation of p53 mRNA can be initiated from an alternate AUG codon at position þ 40 giving rise to a 40 amino acid (aa) N-terminally truncated isoform termed p53/47 (Yin et al., 2002) , also described as DNp53 (Courtois et al., 2002; Ghosh et al., 2004) . The p53/47 does not harbour the most N-terminal p53 transactivating domain (aa 1-40) nor the Mdm2-binding site (aa 17-23) (Kussie et al., 1996) , but retains the second transactivation domain (aa 43-63) (Zhu et al., 1998; Venot et al., 1999) , the complete central DNA-binding domain and the C-terminal oligomerization domain. This latter allows the formation of p53 complexes with different ratios of full-length (FL) p53 to p53/47. Complexes incorporating p53/47 are more resistant to Mdm2-mediated degradation and an increase in the ratio of p53/47 to FLp53 leads to a change in the expression pattern of p53 response genes (Yin et al., 2002) . Additionally, expression of p53/47 in p53-null cells can induce apoptosis, indicating that p53/47 may function autonomously and/or in conjunction with FLp53 to promote p53-directed cellular responses. It has, however, also been suggested that p53/47 behaves solely as an antagonist of p53-mediated growth suppression (Courtois et al., 2002) . Although this appears contradictory and the underlying reasons are unclear, it reinforces the idea that the proportion of p53/47 to FLp53 has implications for the cell biological response to p53 activation, a view that is substantiated by a recent transgenic mouse model demonstrating that overexpression of p53/47 leads to p53-dependent cellular senescence and premature ageing (Maier et al., 2004) . p53/47 might thus be a factor of weight in directing the balance of choices to one or the other set of p53-dependent cell stress responses. Taken together with the observation that the levels of expression of p53/47 vary in tumourderived cell lines these results have generated much interest in the physiological role of p53/47.
Translation initiation of mRNA is an important step in controlling protein synthesis and is the target of different types of signalling pathways. In addition to the more commonly occurring cap-dependent translation initiation in eucaryotes it has also become increasingly evident that translation initiation can occur through alternative mechanisms that do not involve the cap structure. Cap-independent translation is mediated by internal ribosome entry sites (IRES) (Jackson, 2000; Schneider, 2001; Stoneley and Willis, 2004) . These are usually comprised of structured regions in the 5 0 untranslated region (UTR) and were initially identified in viruses (Pelletier and Sonenberg, 1988) but have since been reported in eucaryotic mRNAs and are believed to constitute a major form of regulation of protein synthesis in mammalian cells (Johannes and Sarnow, 1998) . In particular, IRES seem to play a role under conditions when cap-dependent translation is impaired and eucaryotic IRES-dependent translation activity has been linked to specific conditions in the cell such as the G2 phase of the cell cycle (Pyronnet et al., 2000) , apoptosis (Spriggs et al., 2005) or to different stress conditions (reviewed by Holcik and Sonenberg (2005) ) to mention some, but also to support specificity of protein synthesis during development (Creancier et al., 2001) .
Results

Cell stress alters the expression of FLp53 and p53/47
With the present work we aimed to gain further insight into the role of p53/47 and to establish under which conditions p53/47 is expressed. We compared the expression of FLp53 and p53/47 in response to cellular stresses induced by cytotoxic agents. The human breast cancer derived cell lines BT474, BT549 and the human sarcoma cell line MLS-1765 express the endogenous FLp53 protein as shown using the polyclonal CM-1 antibody directed against epitopes present in both p53 proteins. Induction of endoplasmic reticulum (ER) stress using either tunicamycin or thapsigargin or the DNA-damaging drug doxorubicin, enhances endogenous FLp53 and p53/47 levels in a cell type-specific manner (Figure 1a left panel) . The induction of both p53 products is apparent after treatment with all three drugs in the MLS and the BT549. BT474 cells show a different pattern in that doxorubicin induces FLp53 but has no effect on the expression of p53/47, whereas the ER-stress agent thapsigargin imposes little effect on FLp53 levels and instead induces p53/47 (Figure 1a left panel) . This shows that cell-specific responses to various types of stresses result in a differentiated expression pattern of FLp53 and p53/47. When analysing p53 isoforms in H1299 cells expressed from an exogenous p53 complementary DNA (cDNA) lacking p53 5 0 and 3 0 UTRs we find accumulation of both FLp53 and p53/47 after cytotoxic drug treatment in a similar manner to what is observed from the endogenous p53 mRNA in the BT549 and MLS-1765 (MLS) cells (Figure 1a right panel) . Hence, the p53 encoding sequence contains the information required to control p53 levels in the same manner as the endogenous p53 in MLS and BT549 under these conditions.
In parallel studies examining the effect of environmental stress we observed that serum deprivation induces a dramatic switch in the expression of the two p53 isoforms (Figure 1b) . Both BT474 and BT549 cells exhibit a reduction in FLp53 expression concomitant with a strong induction of p53/47 after removal of growth factors. Probing with antibodies directed against the central domain (240) or the N-(DO-1) or C-terminus (421) of p53 confirms the identity of p53/47. P53/47 is detected using the 421 but not DO-1. Thus, it Figure 1 Effects of cell stress on p53 and p53/47 protein expression levels. (a) BT549, BT474 and MLS-1765 cells express endogenous p53. H1299 cells are p53 negative and were transfected using 0.5 mg/0.3 Â 10 6 cells of p53 cDNA. Cells were exposed to either doxorubicin (0.1 mM), tunicamycin (1.2 mM), thapsigargin (0.1 mM) or equal volume of DMSO for 16 h and subsequently harvested, lysed and assessed by immunoblotting using the polyclonal p53 antibody (CM-1). The FLp53 and the truncated p53/47 are indicated. (b) Effect of serum deprivation on FLp53 and p53/47 levels. BT474 and BT549 were cultured in the presence of serum until confluent and then placed into serum-free media for 3 days. P53 expression was analysed using mAbs specific for indicated p53 domain. Most notably, the DO-1 epitope is located in the N-terminus of FLp53 and is not present in p53/47. Blots are representative of three independent experiments. Western blot quantifications were carried out by capturing the chemiluminescence signal using CCD camera and associated software and numbers are given as fold difference.
is, not the recently described delta-C p53 (Bourdon et al., 2005) and we can also confirm it is not derived from another recently proposed splice variant which lacks aa 257-322 (Rohaly et al., 2005) as this protein would be recognized by the DO-1 monoclonal antibody (mAb). The same antibodies were used to confirm the identity of p53/47 in the breast cancer-derived cell lines and in the sarcoma cell line (data not shown and (Yin et al., 2002) ).
Taken together, these results show that cells have the capacity to specifically alter the expression levels of FLp53 and p53/47 in response to various types of stresses.
Induction of FLp53 and p53/47 through changes in the rate of protein synthesis Regulation of p53 stability is known to control p53 expression levels but as p53/47 does not include the Mdm2-binding site and is more stable compared with FLp53, the increase in the expression of p53/47 after drug-induced cell stress cannot easily be explained by changes in protein stability. We set out to investigate the mechanisms by which cell stresses regulate expression of the two p53 isoforms and we first assessed the effect of the cytotoxic drugs on p53 mRNA levels.
As shown in Table 1a , quantitative real-time polymerase chain reaction (qRT-PCR) analysis found no increase in the levels of total p53 mRNA in drug-treated cells. In fact, H1299 cells exhibited a decrease in the abundance of the p53 message after treatment with cytotoxic agents. We have previously observed similar effects of an increase in p53 protein expression concomitant with reduced levels of RNA from transcriptional inactive p53 mutants, indicating that this phenomenon is not related to p53 activity (Yin et al., 2002) . This shows that the induction of p53 and p53/47 does not originate from an increase in wtp53 mRNA levels.
In a recent report it was claimed that p53/47 could not be detected from the wtp53 cDNA and it was instead suggested that a putative splicing variant termed p53EII could explain the presence of p53/47 (Ghosh et al., 2004) . This splice variant retains an intron that harbours an in frame stop codon that excludes the synthesis of FLp53 but not p53/47. We examined the possible contribution of this mRNA species to the stress-induced accumulation of p53/47 from cell lines expressing endogenous p53 by designing primers from p53 exons 2 and 3 (see Figure 2a ). This primer pair amplifies both the wtp53 and the p53EII messages under identical conditions. These products can be separated by size as the extra intron in p53EII makes this message 117 bp longer. As shown in Figure 2a , reverse transcriptase (RT)-PCR analysis of BT549 cells under conditions of cytotoxic stress when p53/47 expression is induced, only amplifies the main p53 mRNA even after 50 rounds. Using a primer pair that is specific for p53EII we can detect this splice variant but at levels that are at least several magnitudes less compared with the wtp53 mRNA and we also find that cells stressed to induce p53/47 show no increase in the amount of p53EII (data not shown). These findings are similar to what has previously been reported and indicate that p53EII is only present in a fraction of all cells (Ghosh et al., 2004) and is unlikely to have much to do with the expression of p53/47. And, most importantly, this study and others find that p53/47 is well expressed from the wtp53 mRNA (Hansen et al., 1998; Courtois et al., 2002; Yin et al., 2002) .
Having confirmed that changes in the p53 RNA levels are not the cause of the observed changes in the expression of p53 isoforms we next determined changes in the rate of p53 synthesis. H1299 cells transfected with wtp53 cDNA and MLS cells were pulse-labelled with 35 S-methionine for 20 min in the presence of the proteosome inhibitor MG132. This allows us to determine the rate of synthesis of FLp53 and p53/47 with minimal interference from changes in protein stability. As shown in Figure 2b , the synthesis of FLp53 and p53/47 are induced after treatment with both DNA damaging and ER stress-inducing drugs in the presence of proteasome inhibitors in a similar manner in either cell type. This confirms that the rate of synthesis of p53 isoforms changes after cytotoxic drug treatment both from the endogenous and from a cDNAderived p53 mRNA. However, that protein stability plays a key role in controlling p53 levels is reflected in the fact that the observed differences in the rate of p53 synthesis after doxorubicin vs tunicamycin treatment does not mirror the p53 steady-state levels (compare Figures 1a and 2b ). Taken together, the increase in H1299 cells transfected with wtp53 and BT549 cells expressing endogenous p53 were exposed to cytotoxic agents (as described in Figure 1a ), and total RNA was extracted. Changes in p53 mRNA levels after drug-induced cell stress were assessed using qRT-PCR.
b H1299 cells transfected with the bi-cistronic construct p53 'C' (see Figure 3 ) expressing GFP and p53 from the same message. The ratio of p53 to GFP mRNA was compared after 45 rounds of qRT-PCR and the data shows that the levels of p53 mRNA is similar to that of GFP. This shows that cell stress does not result in a relative increase in the amount of p53 mRNA compared to GFP mRNA, demonstrating the integrity of the bi-cistronic mRNA under these conditions (see also Figure 3c ). The data presented is the average of three independent experiments normalized against DMSO-treated cells (amount of DMSO-treated mRNA ¼ 100%). No changes were noted in the levels of control mRNAs (TBP and b2M).
Expression of p53 and p53/47
MM Candeias et al expression of p53 isoforms in the presence of proteasome inhibitors and the lack of correlation between p53 mRNA levels and p53 protein levels show that translation control of the p53 mRNA plays an important role in changing the relative levels of expression of FLp53 and p53/47 after cell stress.
Alternative mechanisms of mRNA translation initiation control expression of FLp53 and p53/47 Based on the idea that mRNA translation plays an important role in controlling the expression pattern of p53 isoforms during cell stress we next set out to investigate the mechanisms behind p53 mRNA translation control. As cell stress can tip mRNA translation initiation from cap-dependent towards cap-independent mechanisms it prompted us to insert a RNA hairpin structure 40 nt (nucleotide) upstream of the FLp53 initiation site (first AUG) in the wtp53 mRNA lacking 5 0 and 3 0 UTRs (p53 'A') in order to test which type of translation control governs the p53 message. Hairpin insertions are frequently used as a tool to inhibit ribosome scanning of the mRNA and by inserting the hairpin between the Cap structure and first AUG we can thereby suppress cap-dependent translation initiation of the p53 message. The inclusion of the hairpin does not lead to a complete block of p53 translation but instead induces a switch in the ratio of the p53/47 to the FLp53 protein in favour of the former (Figure 3a, p53 0 A 0 ). Moving the hairpin in close proximity to the first AUG (5 nt upstream of the first AUG) shows the same effect (data not shown). The rate of synthesis of p53/47 is further enhanced if the first AUG is removed in the presence of the hairpin structure (compare constructs p53 'A' and 'B' in Figure 3a ). These results allow us to speculate that initiation from the first and second AUGs may be regulated separately and that the putative alternative mechanism driving synthesis of p53/47 is normally masked by cap-dependent translation initiation.
We next produced a p53 construct harbouring a stop codon upstream of the second AUG (p53 38Stop). This (a) Comparison of endogenous levels of wtp53 mRNA and the alternative splice variant p53EII before and after drug treatment. The putative p53EII splice variant retains an intron between exons 2 and 3 which results in an in frame stop codon before the initiation site of p53/47 and has previously been suggested to explain the expression of p53/47. BT549 cells were stressed to induce p53/47 expression (see Figure 1a ) before total RNA was extracted. P53 mRNA levels were determined by RT-PCR using primer pair 'A'. As p53EII has an extra intron it can be separated from wtp53 mRNA by its larger size. After 50 rounds of amplification the PCR products were separated on agarose gels and visualized by ethidium bromide staining. These results show no detectable amount of the p53EII message under conditions when p53/47 is expressed. (b) H1299 cells transfected with wtp53 cDNA without UTRs or MLS cells expressing endogenous p53 were treated with cytotoxic drugs before the cells were labelled with 35 S-methionine for 20 min in the presence of 25 mM of the proteasome inhibitor MG132. p53 products were immunoprecipitated using the CM-I polyclonal sera and the amount of newly synthesized p53 products were estimated using phosphoimager analysis. The changes in the rate of synthesis of the FLp53 and the p53/ 47 are similar in H1299 cells expressing wtp53 cDNA compared with MLS cells. Synthesis of p53/47 was not detected in the MLS cells without drug treatment (DMSO) over this short time period. mutation mimics the thymidine insertion present in the mutant p53 of the 21PT cells, which have a high expression of p53/47 only (Wazer et al., 1994) .
Consistent with the 21PT cells, H1299 cells expressing the p53 38Stop construct display a high level of p53/47 and no detectable amount of FL protein (Figure 3b ). 0 or 3 0 UTRs. The region including the initiation sites for FLp53 at þ 1 and p53/47 at þ 40 is highlighted. H1299 cells transfected with indicated constructs were analysed by western blot. Insertion of a hairpin structure 40 nt upstream of the first AUG (construct 'A') suppresses FLp53 but promotes p53/47 expression, indicating that translation initiation from the first and second AUG is directed through independent mechanisms. Deletion of the first AUG (construct 'B') further enhances p53/47 expression. Insertion of an ORF (GFP) (construct 'C') in the 5 0 end of the p53 message has a similar effect on expression of the p53 isoforms as the insertion of the hairpin. (b) Codon 38 was exchanged for a stop codon, which represents the natural occurring mutant in the PT21 tumour cell line. The increase in p53/47 expression shows that pre-termination of FLp53 synthesis before the initiation of p53/47, just like prevention of cap-dependent FLp53 initiation (construct A þ C), stimulates p53/47 expression. (c) Left panel. Treatment of cells with ER-linked cytotoxic drugs (thapsigargin and tunicamycin) under conditions when cap-dependent translation of the p53 mRNA is minimized (construct 'C') shows an increase in expression of both p53 products. But at the same time the DNA-damaging agent doxorubicin that has no apparent effect. Middle panel. Removal of the CMV promoter from the vector results in a depletion of p53 isoform expression from the mono-and bi-cistronic constructs, demonstrating that there are no cryptic promoters within the bi-cistronic sequence (see also Table 1 ). Right panel. Northern blot of total RNA extracted from H1299 cells transfected with p53 wt or bicistronic p53 'C' and treated with tunicamycin, using a 32 P-labelled probe corresponding to p53 shows a single transcript for both constructs. Triple amount of the p53 'C' RNA extract was added to increase the detection of p53 transcripts. (d) In vitro transcribed capped p53 mRNA was translated in vitro in the presence of 35 S-labelled methionine and increasing concentration of the cap-analogue 7-m-GTP. The data shows that 7-m-GTP preferentially inhibits translation of FLp53. (e) Point mutations were inserted in the sequence flaking the first AUG initiator codon (Kozak sequence) to progressively weaken the efficiency of translation initiation of the first AUG. The resulting constructs were translated in vitro in the presence of 20 mM 7-m-GTP. The expression of p53/47 becomes progressively more sensitive to inhibition of cap-dependent translation as a result of a weaker initiation at the first AUG. Taken together, these results indicate that cap-dependent initiation of FLp53 translation suppresses cap-independent synthesis of p53/47 and that cap-independent mechanisms of translation initiation guide synthesis of p53 isoforms after ER-linked cell stress.
Blocking the translation initiation from the first AUG is thus not crucial to obtain enhanced levels of p53/47, suggesting that ribosomal elongation of the FLp53 can actively suppress initiation from the second AUG. It could, however, be argued that the restrain of initiation from the first AUG and the 38Stop mutant reflect different mechanisms of regulation and that the induction of p53/47 in the '38Stop' context involves ribosomal re-initiation. Although this is common in prokaryotic systems, it is a rare event in eucaryotic translation (Jackson, 2000) and is unlikely to explain the dramatic increase in p53/47 expression seen by the '38Stop'.
To further examine the potential role of capindependent mechanisms in controlling the synthesis of p53 products we inserted another open-reading frame (ORF) (in this case we used green fluorescent protein (GFP)) in the 5 0 end of the p53 coding sequence in order to create a bi-cistronic mRNA that will ensure minimum influence of cap-dependent initiation of p53 mRNA translation (termed p53 'C'). As shown in Figure 3a , expression of p53/47 was still detected from this bicistronic vector, confirming the capacity of the p53 mRNA to initiate synthesis of p53/47 independently of the canonical cap-binding system under normal cell culture conditions.
We next used this bi-cistronic construct to investigate how synthesis of the two p53 isoforms respond to different types of cell stress under conditions of selective cap-independent translation. As shown in Figure 3c , ER stress induces a significant induction of both p53 proteins from the bi-cistronic p53 'C' construct. The augmentation in p53/47 protein levels is similar using tunicamycin and thapsigargin but that of FLp53 varies. As these experiments were carried out in the absence of proteasome inhibitors it is possible that some of the differences in the expression levels of FLp53 are due to differences in the rate of degradation. In contrast, however, doxorubicin has no effect on neither FLp53 nor p53/47 synthesis. These data show that specific capindependent translation initiation drives the synthesis of p53 isoforms in response to ER stress, but not DNA damage. Furthermore, as ER stress induces synthesis of both p53 isoforms under cap-independent translation conditions in the absence of the p53 5 0 UTR it also shows that a regulatory RNA sequence located in the p53 coding region has the capacity to promote capindependent translation initiation of both p53 isoforms (see discussion).
The mRNA ratio of p53 to GFP (Table 1b) (Hellen and Sarnow, 2001) does not change after cell stress, confirming the integrity of the p53 'C' message when expressed in H1299 cells and demonstrates that the expression of p53 isoforms under cap-independent conditions are not owing to the activation of cryptic promoters or alternative splice variants. The absence of cryptic promoter activity within the bi-cistronic mRNA is also confirmed by removing the cytomegalovirus (CMV) promoter from the vector, which results in the depletion of expression of p53 isoforms from both the mono-and the bi-cistronic constructs (Figure 3c, middle  panel) . Northern blot analysis shows the presence of full-length bicistronic RNA p53 'C' and no smaller RNA species, reconfirming that the GFP and p53 cistrons are part of a single transcript (Figure 3c , right panel).
We also sought a different approach to investigate cap-dependent vs cap-independent translation of the p53 mRNA and we performed p53 mRNA translation in vitro. Translation of in vitro transcribed capped wtp53 mRNA was carried out using rabbit reticulocyte lysates in the presence of an increasing concentration of 7-m-GTP. Free 7-m-GTP competes with 7-m-GTP capped mRNAs for the binding of eucaryotic translation initiation factor (eIF)4E and thereby impeding the translation of capped mRNAs. Figure 3d shows that synthesis of FLp53 is more sensitive to increasing 7-m-GTP concentration compared with p53/47 when synthesized from the same wtp53 mRNA. Weakening the optimal initiation sequence (Kozak sequence) flanking the FLp53 initiation site ( þ 1) leads to a shift in the level of synthesis of FLp53 towards p53/47, presumable through an increase in pre-initiation complexes missing the first AUG and instead initiating at the second AUG (Figure 3e ). The initiation of the FLp53 from the different Kozak sequences is equally sensitive to treatment with the 7-m-GTP but, at the same time, the increase in initiation observed from the second AUG becomes successively more sensitive. This is in line with what is expected if the increase in initiation from the second AUG becomes more cap-dependent after weakening the Kozak sequence adjacent to the first AUG.
Thus, the observation that cap-independent mechanisms of mRNA translation initiation govern the synthesis of the p53/47 can also be observed under in vitro conditions. However, we do not observe an increase in the synthesis of p53/47 by blocking cap-dependent initiation from the first AUG by adding 7-m-GTP, indicating that translation of the p53 message in vitro does not fully mimic p53 translation in vivo.
Identification of p53 mRNA regions responsible for mRNA translational control As the cDNA vectors used to express exogenous FLp53 and p53/47 in these experiments lack both 5 0 and 3 0 UTRs it suggests that the synthesis of the two p53 proteins can be regulated via alternative translation initiation mechanisms that are solely dependent on regions within the p53 coding sequence. However, it has been demonstrated in both human, mouse and yeast models that the UTRs of p53 can mediate control of its translation (Mosner et al., 1995; Fu et al., 1999; Mokdad-Gargouri et al., 2001) . We therefore addressed the putative role of the mRNA sequence flanking the 5 0 end of the p53 encoding sequence in controlling p53/47 synthesis. In Figure 4a we show that the 5 0 UTR suppresses p53/47 synthesis slightly both in a capdependent and a cap-independent setting, indicating that the 5 0 UTR of p53 has no apparent specific effect on cap-independent translation initiation of the p53 mRNA under these three conditions.
The previous results in Figure 3a show that induction of p53 synthesis after ER-stress can be mediated via cap-independent mechanisms but as doxorubicin has no effect under cap-independent conditions it is possible this is instead mediated via cap-dependent mechanisms (compare Figures 2b and 3c ). This makes it less likely that the different mechanisms of induction of p53 synthesis are mediated via the same mRNA region.
We tested this by making two different constructs (see Figure 4b ). In the first construct we fused the first 120 nt of the encoding region of p53 to the 5 0 end of EGFP (N120-EGFP). In the second we simply deleted the first 120 nt that normally encodes the p53 N-terminus (construct p53 'E') and this construct gives rise to p53/ 47 only. These constructs allow us to test the capacity of the region 5 0 of the second AUG to mediate control of synthesis independently of other regions of the p53 mRNA located down stream of the second AUG. When we express N120-EGFP we observe that this mRNA gives rise to the N120-EGFP fusion protein as well as EGFP itself (compare with FLp53 and p53/47) and that the expression of both protein products is induced after treatment with tunicamycin, but not with doxorubicin. On the contrary, when we treat cells expressing the p53 'E' construct that lacks the first 120 nt we observe an induction after doxorubicin but not after tunicamycin treatment. This indicates that the first 120 nt of the p53 encoding mRNA sequence are not essential for cap-dependent induction of p53 mRNA translation mediated through doxorubicin-induced cell stress pathway, suggesting that p53 translation in response to doxorubicin is influenced by regions located down stream of the initiation site for p53/47. Furthermore, the region encoding the first 40 aa of p53 is by itself sufficient and necessary to promote cap-independent induction of mRNA translation after ER-induced stress.
P53-induced apoptosis is dependent on the type of cell stress and expression of p53 isoforms. To gain physiological insight into the cell biological response to FLp53 and p53/47 induction by stress, BT549 cells were exposed to doxorubicin and tunicamycin for 16 h and analysed for induction of apoptosis using flow-cytometry. Both drugs induce apoptosis but with a stronger effect observed by doxorubicin at these concentrations (Figure 5a ). H1299 cells expressing the two different p53 isoforms from the wtp53 cDNA were treated in the same way 36 h after transfection and showed a similar induction of apoptosis (Figure 5b) . However, H1299 cells expressing p53/47 are only to a very low degree, affected by treatment with doxorubicin but show a significant induction of apoptosis after exposure to tunicamycin (similar results were obtained with thapsigargin, data not shown). Staining of transfected H1299 cells reveals no significant difference in the sub cellular localization of the two p53 isoforms before or after drug treatment (data not shown). This indicates that proapoptotic pathways induced by different types of cell stress can be supported by different p53-induced gene products and might also help to understand previous contradictory results regarding the capacity of p53/47 to induce apoptosis.
Discussion
In this study, we show that FLp53 and the alternative translation product p53/47 are synthesized through 0 UTR, and the p53 'C' construct (see Figure 3) . The presence of the 5 0 UTR results in a weak induction of FLp53 expression and a decrease in expression of p53/47 under cap-dependent and -independent translation, as determined by immunoblotting. This indicates that the 5 0 UTR does not directly influence cap-independent expression of the p53 mRNA. (b) The first 120 nt of the p53 mRNA, corresponding to the region between the first and second AUG, were inserted in front of EGFP (N120-EGFP). This construct expresses the N120-EGFP fusion protein as well as EGFP (see upper blot). The first 120 nt were deleted from the p53 encoding sequence to create construct (p53 'E'). Doxorubicin induces p53/47 expression from the 'E' but not from the N120-EGFP mRNA. On the contrary, tunicamycin induces expression of the N120-EGFP fusion protein and EGFP itself from the N120-EGFP construct but it has no effect on synthesis from the p53 'E' message. These data show that stimulation of p53 mRNA translation by ER-induced cell stress is mediated by the first 120 nt of the p53 coding sequence whereas the cap-dependent induction of expression through doxorubicin requires regions further downstream. different and independent mechanisms of mRNA translation initiation. We demonstrate that expression of the p53 isoforms increase after cells have been subjected to different types of stress without an increase in p53 mRNA levels or alternative splice products. This is in line with previous studies demonstrating that levels of p53 mRNA in cells poorly reflects the expression of the p53 protein (Fu et al., 1996; Yin et al., 2002) and further underlines that RNA levels is not a useful determinant when looking for the cause of changes in p53 protein levels. The results presented here demonstrate that in addition to the more commonly studied pathways that are known to control p53 expression through its degradation the control of p53 mRNA translation forms an additional important mechanism by which p53 levels are regulated. In line with this is the observation that the induction of p53/47 after cell stress does not require the presence of the Mdm2-binding domain in p53, which is shown by deletion of the first AUG in the p53 message.
One of the aims of this report was to investigate different aspects of the mechanisms that control the expression of p53/47, and a major observation is the increase in synthesis of p53/47 after blockage of capdependent ribosomal scanning of the p53 mRNA under normal cell culture conditions. It is interesting from a translational regulatory point of view that the sequence upstream of the p53/47 initiation site, which encodes the first 40 aa of the FLp53 is in facto the 5 0 UTR of p53/47. Examples in which encoding sequences in the 5 0 UTR control the translation initiation of downstream ORFs are well known (Gray and Wickens, 1998) . These regions may lack a translation termination site like in the case of 5 0 UTR of p53/47 or they can be short ORFs. Either way they can impose changes in the RNA structure and the resulting exposure of cryptic initiation sites or regulatory domains, and their encoded aa sequence is sometimes directly involved with the translation machinery (Geballe and Morris, 1994) . Based on this, it is possible that the 5 0 UTR of p53/47 harbours an internal ribosome entry site (IRES) and that inhibition of the cap-dependent translation of the p53 message paves the way for cap-independent initiation of the second AUG and the synthesis of p53/47, perhaps by preventing ribosome-induced alterations in the 5 0 UTR structure of p53/47. This offers a better explanation for the fact that suppression of capdependent translation of the p53 message actually promotes the synthesis of p53/47. Based on this, it can be speculated that cell starvation in which we observe a down regulation of FLp53 expression and at the same time an induction of p53/47 from the endogenous p53 mRNA, physiologically resembles the artificially induced cap-independent translation created by inserting a hairpin or an ORF in the 5 0 UTR of the p53 message. Internal ribosome entry (IRES)-dependent translation initiation is generally regarded as being responsible for cap-independent mRNA translation and cell stress has been linked to IRES activity (Holcik and Sonenberg, 2005) . Few proteins would be more suitable than p53 to have mRNA translation control under cell stressdependent mechanisms of initiation. It is, thus, tempting to speculate that IRES-like translation regulation can offer an explanation to the cap-independent induction of p53/47 expression. This proposition is indeed attractive and it could also explain how translation of the p53 message is stimulated after ER-mediated cell stress as IRES-dependent translation has been shown to be responsive to ER stress induced by agents such as tunicamycin and thapsigargin (Warnakulasuriyarachchi et al., 2004) . However, not all of our data is consistent with the definition of an IRES driving synthesis of p53 isoforms under cap-independent conditions: (i) The cap-independent initiation of p53/47 occurs in an in vitro context, even though we do not observe an actual increase in p53/47 synthesis after blockage of capdependent translation, which is the case in transfected cells. This is unusual for eucaryotic IRESs and in vitro activity is usually linked to viral IRESs. (ii) We have not yet been able to isolate a p53 mRNA sequence that can be cloned into a chimeric luciferase reporter construct and exhibit IRES activity (data not shown). This latter can, of course, simply be owing to the fact that the structure of p53 mRNA is not 'IRES-favourable' in the luciferase reporter setting we have used. On the other hand, we have identified the first 120 nt of the p53 encoding region to harbour the ER stress-dependent domain. Based on these accounts, however, we propose that the p53 mRNA harbours an 'IRES-like' sequence capable of supporting translation initiation of the p53 mRNA in a cap-independent and stress responsive manner. With regard to the role of a putative IRES in supporting cap-independent translation of the p53 message it is puzzling that under cap-independent conditions, and in the absence of the p53 5 0 UTR, we observe an induction of both p53 isoforms after ER stress. It has, however, recently been demonstrated that the human immunodeficiency virus (HIV)-2 genomic RNA contains an IRES downstream of the initiation site (Herbreteau et al., 2005) and this might help to understand how a downstream encoding RNA sequence could support IRES-dependent initiation of the first AUG in the p53 mRNA. It is also interesting that like with the p53 message, the HIV-2 translation regulatory region controls the synthesis of more than one isoform. Nevertheless, if this IRES-like activity in the p53 encoding sequence will later come to stand for a strict IRES or for an internal regulatory sequence, we do not yet know but what is important in this context is that cap-independent mechanisms of initiation regulate the translation of the p53 mRNA under the control of certain stress-induced pathways.
When we look at the mechanism of p53 induction by the DNA-damaging doxorubicin or through ER stressinducing agents, we find that both types of stresses induce p53 isoforms expression. But it turns out that these two stress pathways appear to utilize different regions of the encoding sequence of the p53 mRNA to stimulate p53 synthesis and perhaps also different mechanisms of mRNA translation initiation. ER stress only requires the region encoded by 120 nt located between the first and the second AUG in order to stimulate translation, whereas cap-dependent induction by doxorubicin instead requires the encoding sequence of p53/47.
We do not yet know the molecular pathway behind ER stress-induced regulation of cap-independent translation of the p53 mRNA but signalling cascades linking the ER to the translation machinery have been identified previously. One factor that plays a key role is the protein kinase protein kinase regulated by RNA-like ER kinase PERK which is associated with the ER and which phosphorylates the initiation factor eIF2a which, in turn, results in a reduction in global protein translation (Harding et al., 1999) . PERK-mediated reduction of cap-dependent initiation from the first AUG could, thus, pave the way for initiation of the second AUG and thereby fulfil one of the criteria for stimulating initiation of p53/47 synthesis. It has also been reported that phosphorylation of the eIF2a is a prerequisite for promoting initiation through certain IRES (Fernandez et al., JBC, 2002) and, hence, PERK could as well fulfil the second criteria for the cap-independent induction of p53 mRNA translation.
It is becoming evident from these data and from other studies that the translational regulation of p53 holds promises to be as intriguing as most of p53s other aspects. This is not surprising taking into account the critical role p53 is playing in cell survival. It is therefore of little surprise that the induction pattern of the p53 isoforms after stress is cell type-specific. An example of this are the differences we observe between the induction pattern of p53 isoforms from the endogenous p53 mRNA in MLS and BT549 cells as well as from H1299 cells transfected with wtp53 cDNA and those we observe in BT474 cells. Furthermore, in Saccharomyces cerevisiae the 5 0 UTR of p53 suppresses synthesis of FLp53 but supports the synthesis of a truncated form that most likely represents p53/47 (Mokdad-Gargouri et al., 2001) . This is different from what we observe in mammalian cells but it well illustrates how cell-typespecific factors tightly control translation of the p53 message. It has also been reported that p53 itself can mediate control of its own synthesis through interaction with its 5 0 UTR (Mosner et al., 1995) and a recent publication reports that the 5 0 UTR is responsible for mediating translation control of p53 after g-irradiation (Takagi et al., 2005) . This could indicate that regions within the coding domain as well as within the 5 0 UTR mediate different types of stress-dependent translation control of p53 synthesis. But how these reports relate to cap-independent translation of the p53 mRNA, or to p53/47 synthesis, remains to be investigated. The role of the p53 5 0 UTR seems to play only a limited role in mediating the stress-response as the induction of synthesis of p53 isoforms we observe here is similar regardless whether it is from the endogenous message or from cells transfected with a cDNA lacking the UTRs (see Figure 2b) .
A major question is the physiological role of the alternative translation mechanism for p53 and p53/47. Why is it that cells express different and specific ratios of the two p53 isoforms in response to different types of stress? As p53/47 harbours distinct features in terms of stability and activity and can oligomerize with FLp53, a possible explanation could be that the expression of the two isoforms at different levels would allow activation of the p53 pathway to become more differentiated. Hence, by inducing different rates of expression of p53/ 47 and pFLp53, or by switching to the synthesis of p53/ 47 only, the activity of p53 complexes becomes more multi-facetted compared to what takes place under conditions when only FLp53 is expressed. Additionally, as the induction of p53/47 takes place after stress, this would indicate that the potential repertoire of p53 activities under these conditions is enhanced. Furthermore, as p53 activity also induces the expression of Mdm2 which targets FLp53, but not p53/47, for degradation, the expression of p53/47 will also help to ensure that p53 activation does not lead to its own degradation under conditions when an active p53 response is needed to control cell proliferation or apoptosis.
It is interesting that translation of the p53 message has evolved to become regulated by stress-induced pathways, but it is perhaps not unexpected. As certain types of cell stress pathways are known to influence mechanisms that control mRNA translation, and as p53 function is reliant on its capacity to rapidly respond to cell stress, it is not surprising that p53 mRNA translation is responsive to cell stress. For example, the expression of apoptosis linked APAF-1 (Coldwell et al., 2000) , X-linked inhibitor of apoptosis protein (Holcik et al., 1999) as well as the hypoxia response factor hypoxia-inducible factor-a are regulated through IRESs (Lang et al., 2002) . Hence, the capacity of the p53 mRNA to coordinate the synthesis of p53 products with the synthesis of executing stress-response factors could form an important part in the p53 response to changes in the cellular environment. An example of this is illustrated by the observation that doxorubicininduced apoptosis seems primarily to depend on the presence of FLp53 whereas ER-stress, on the other hand, induces apoptosis through both FLp53 and p53/47. This suggests that different proapoptotic pathways can be supported by different combinations of the p53 isoforms, underlining the role for p53 mRNA translation control as an important factor in generating a differentiated p53 response to various types of cell stress.
Materials and methods
Culture and constructs H1299 (p53 negative human-lung carcinoma cells), MLS-1765 (human sarcoma-derived cell line) were cultured in Rosewell Park Memorial Institute 1640 medium, and BT474, BT549 (human breast carcinoma cell lines) cultured in Dulbecco's modified Eagle's medium, in the presence of 10% fetal calf serum (FCS) and penicillin/streptomycin. All constructs used are in the pCDNA3 vector and generated according to standard protocols. Transfections were made in the H1299 cell line. Molecular cloning was carried out according to standard methods and mutations were generated by using PCR and confirmed by DNA sequencing. All expression constructs used are in the pcDNA3 vector. Cells were transfected with 0.5 mg DNA per 3 Â 10 5 cells with 3.0 ml Genejuice (MerckBiosciences, UK) per microgram of DNA and the total amount of DNA was kept constant by adding empty vector. Cells were treated with doxorubicin (0.1 mM), tunicamycin (1.2 mM), thapsigargin (0.1 mM) or equal volume of dimethylsuphoxide (DMSO) for 16 h where indicated. Cell lysates where prepared by washing the cells twice in cold phosphate-buffered saline (PBS) before using a rubber policeman to detach the cells and cell pellets were collected by brief cf. The cells where lysed in buffer A containing 1% Nonidet P-40, 150 mM NaCl, 20 mM Tris pH 7.4 in the presence of Complete protease inhibitor cocktail (Roche, Mannheim, Germany). Protein concentrations were measured using Bradford (Home made) and a total of 20 mg of protein was separated by 10% sodium dodecylsulpahte-polyacrylamide gel electrophoresis (SDS-PAGE). Chemiluminescence signals from western blots were captured and expression of genes quantified using a cooled CCD camera and associated software (5000 series camera and Bio-1D software, Vilber Lourimat, France). For the immunoprecipitation assays cells were lysed in buffer A and pre-cleared with mouse immunoglobulin G and protein G-sepharose before the p53-specific mAbs 241 and CM-1 were added. The beads were then washed extensively in buffer A and two times in PBS before boiling in SDS loading buffer.
Protein labelling
35 S-methionine labelling was carried out by culturing the cells in methionine-free medium including 2% dialysed FCS for 1 h and 25 mM of the proteasome inhibitor MG132 (Merck Biosciences, UK), where indicated. 0.3 mCi of 35 S-labelled L-(S)-methionine (Amersham, UK) was added for 20 min, unless other durations are indicated, and p53 proteins were immunoprecipitated and separated by SDS-PAGE. In vitro translation was performed using the coupled rabbit reticulocyte lysate system according to the manufacturer's protocols (Promega, Madison, WI, USA) and in vitro transcribed capped mRNA (Ambion, Austin, TX, USA). Quantification of radioactively labelled products was determined using phosphoimager (Bio-Rad) and Quantity One software.
Flow cytometry
Propidium iodide staining of cells was performed as described previously (Nicoletti et al., 1991) . Cultured cells were treated with indicated cytotoxic drug or growth conditions, and subsequently both floating and adherent cells were pelleted before fixation and permeabilization with ice-cold 70% ethanol. The cells were then washed twice in PBS before incubation with RNase at 371C for 30 min. Propidium iodide (50 mg/ml; Sigma-Aldrich, St Louis, MO, USA) was then added, and the propidium iodide fluorescence emission was analysed with LSR flow cytometer (Becton-Dickinson, San Jose, CA, USA). Events that fell within the hypodiploid region (sub-G0/G1) were accounted for as apoptotic events and enumerated using the CellQuest software, the results expressed as a percentage of the total events.
qRT-PCR and Northern blotting Total cellular RNA was extracted using TRIzol Reagent (Invitrogen, Paisley, Scotland). cDNA synthesis was carried out using the Moloney murine leukaemia virus reverse transcriptase (Invitrogen). Triplicate samples were subjected to quantitative PCR using LightCycler SYBR Green I and hybridization probes systems (Roche). PCR for TATA Boxbinding protein and b 2 microglobulin mRNA was used as an internal control. The abundance of p53, p53EII and GFP mRNAs was calculated with standard curves from the respective quantified cDNAs. The primer pairs used for PCR are: (A) Located in the second and third exons of p53, respectively and can amplify both the wtp53 and the p53EII message and originates products of different sizes if detecting both messages and was used for Figure 2a : forward 5 0 -CCGC AGTCAGATCCTAGCG-3 0 and reverse 5 0 -TGGGTCTTCA GTGAACCATTGT-3 0 . (B) Covering the second exon (forward) and the junction between the second exon and second intron of p53 (reverse), respectively, and amplifies p53 RNA products in which the second intron has not been spliced out: forward 5 0 -CCGCAGTCAGATCCTAGCG-3 0 and reverse 5 0 -GATCCACTCACAGTTTCCATAGGTC-3 0 . (C) Located in the fourth and fifth exons of p53 and was used to quantify p53 products (Table 1): forward 5 0 -TGGGCTTCTTGCATT CTGG-3 0 and reverse 5 0 -GCTGTGACTGCTTGTAGATGG C-3 0 . (D) Specific for GFP and used to calculate the ratio of p53 to GFP message from the bi-cistronic construct p53 'C' (Table 1b) : forward 5-AGCAAAGACCCCAACGAGAA-3 and reverse 5-GTCCATGCCGAGAGTGATCC-3 0 . For Northern blotting, total RNAs from H1299 cells, transfected with p53 wt construct or p53 'C' bicistronic construct and treated with tunicamycin, were resolved on 1% agarose gel, blotted on nylon membrane and hybridized with a 171 nt 32 P-labelled probe derived from p53 cDNA.
